Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo

Ya Ling Hsu, Po Lin Kuo, Tz Fei Tzeng, Shu Chiao Sung, Ming Hong Yen, Liang Tzung Lin, Chun Ching Lin

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background and Aim: Huang-lian-jie-du-tang (HLJDT; Japanese name, oren-gedoku-to) is a traditional Chinese medicine prescription known to possess anti-inflammatory activity. Our study reports here for the first time the anticancer effect of HLJDT in two human liver cancer cell lines, Hep G2 and PLC/PRF/5. Methods: Inhibition of cell proliferation by HLJDT was measured by sodium 3′-(1-(phenylamino-carbonyl)-3,4-tetrazolium)-bis(4-methoxy-6- nitro) benzene-sulfonic acid hydrate (XTT) assay. Clonogenic assay was used to elucidate the possible differences in long-term effects of HLJDT on human liver cancer cells. Cell cycle distribution was determined by flow cytometry. Apoptosis was detected using electrophoresis and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick endlabeling (TUNEL) assay. Protein expressions were determined by immunoblot assay. The activity of nuclear factor-kappa B (NF-κB) was determined by Trans-AM ELISA kit. In vivo tumor activity was assessed by xenograft study. Results: HLJDT significantly increased the expression of inactivated phospho-Cdc2 and phospho-Cdc25C, and decreased the levels of cyclin A, cyclin B1, Cdc2, and Cdc25C, thereby contributing to cell-cycle arrest. HLJDT increased the expression of Bax and Bak, but decreased the level of Bcl-2 and Bcl-XL, and subsequently triggered the mitochondrial apoptotic pathway. In addition, HLJDT also inhibited cell-survival signaling by enhancing the amount of IκBα in the cytoplasm, reducing the level and activity of NF-κB in the nucleus, and subsequently attenuating the expression of Bcl-XL in Hep G2 and PLC/PRF/5 cells. The inhibitory effect mediated by HLJDT on cell growth was also demonstrated in a nude mouse model, in which the liver cancer cells induced tumor xenograft shrank considerably following treatment with HLJDT. Conclusions: Taken together, these results suggest a potential anticancer effect of HLJDT against human liver cancer cells.

Original languageEnglish
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume23
Issue number7 PT2
DOIs
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Chinese Traditional Medicine
Liver Neoplasms
Cell Cycle Checkpoints
Prescriptions
Apoptosis
NF-kappa B
Heterografts
oren gedoku to
In Vitro Techniques
huang-lien-chieh-tu-tang
Cyclin B1
Cyclin A
Sulfonic Acids
DNA Nucleotidylexotransferase
Hep G2 Cells
Benzene
Nude Mice
Names
Electrophoresis
Neoplasms

Keywords

  • Apoptosis
  • Cell cycle
  • Huang-lian-jie-du-tang
  • Liver cancer
  • Nuclear factor-kappa B (NF-κB)

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. / Hsu, Ya Ling; Kuo, Po Lin; Tzeng, Tz Fei; Sung, Shu Chiao; Yen, Ming Hong; Lin, Liang Tzung; Lin, Chun Ching.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 23, No. 7 PT2, 2008.

Research output: Contribution to journalArticle

@article{14370f4901b2488eb719652bb196aeed,
title = "Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo",
abstract = "Background and Aim: Huang-lian-jie-du-tang (HLJDT; Japanese name, oren-gedoku-to) is a traditional Chinese medicine prescription known to possess anti-inflammatory activity. Our study reports here for the first time the anticancer effect of HLJDT in two human liver cancer cell lines, Hep G2 and PLC/PRF/5. Methods: Inhibition of cell proliferation by HLJDT was measured by sodium 3′-(1-(phenylamino-carbonyl)-3,4-tetrazolium)-bis(4-methoxy-6- nitro) benzene-sulfonic acid hydrate (XTT) assay. Clonogenic assay was used to elucidate the possible differences in long-term effects of HLJDT on human liver cancer cells. Cell cycle distribution was determined by flow cytometry. Apoptosis was detected using electrophoresis and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick endlabeling (TUNEL) assay. Protein expressions were determined by immunoblot assay. The activity of nuclear factor-kappa B (NF-κB) was determined by Trans-AM ELISA kit. In vivo tumor activity was assessed by xenograft study. Results: HLJDT significantly increased the expression of inactivated phospho-Cdc2 and phospho-Cdc25C, and decreased the levels of cyclin A, cyclin B1, Cdc2, and Cdc25C, thereby contributing to cell-cycle arrest. HLJDT increased the expression of Bax and Bak, but decreased the level of Bcl-2 and Bcl-XL, and subsequently triggered the mitochondrial apoptotic pathway. In addition, HLJDT also inhibited cell-survival signaling by enhancing the amount of IκBα in the cytoplasm, reducing the level and activity of NF-κB in the nucleus, and subsequently attenuating the expression of Bcl-XL in Hep G2 and PLC/PRF/5 cells. The inhibitory effect mediated by HLJDT on cell growth was also demonstrated in a nude mouse model, in which the liver cancer cells induced tumor xenograft shrank considerably following treatment with HLJDT. Conclusions: Taken together, these results suggest a potential anticancer effect of HLJDT against human liver cancer cells.",
keywords = "Apoptosis, Cell cycle, Huang-lian-jie-du-tang, Liver cancer, Nuclear factor-kappa B (NF-κB)",
author = "Hsu, {Ya Ling} and Kuo, {Po Lin} and Tzeng, {Tz Fei} and Sung, {Shu Chiao} and Yen, {Ming Hong} and Lin, {Liang Tzung} and Lin, {Chun Ching}",
year = "2008",
doi = "10.1111/j.1440-1746.2008.05390.x",
language = "English",
volume = "23",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "7 PT2",

}

TY - JOUR

T1 - Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo

AU - Hsu, Ya Ling

AU - Kuo, Po Lin

AU - Tzeng, Tz Fei

AU - Sung, Shu Chiao

AU - Yen, Ming Hong

AU - Lin, Liang Tzung

AU - Lin, Chun Ching

PY - 2008

Y1 - 2008

N2 - Background and Aim: Huang-lian-jie-du-tang (HLJDT; Japanese name, oren-gedoku-to) is a traditional Chinese medicine prescription known to possess anti-inflammatory activity. Our study reports here for the first time the anticancer effect of HLJDT in two human liver cancer cell lines, Hep G2 and PLC/PRF/5. Methods: Inhibition of cell proliferation by HLJDT was measured by sodium 3′-(1-(phenylamino-carbonyl)-3,4-tetrazolium)-bis(4-methoxy-6- nitro) benzene-sulfonic acid hydrate (XTT) assay. Clonogenic assay was used to elucidate the possible differences in long-term effects of HLJDT on human liver cancer cells. Cell cycle distribution was determined by flow cytometry. Apoptosis was detected using electrophoresis and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick endlabeling (TUNEL) assay. Protein expressions were determined by immunoblot assay. The activity of nuclear factor-kappa B (NF-κB) was determined by Trans-AM ELISA kit. In vivo tumor activity was assessed by xenograft study. Results: HLJDT significantly increased the expression of inactivated phospho-Cdc2 and phospho-Cdc25C, and decreased the levels of cyclin A, cyclin B1, Cdc2, and Cdc25C, thereby contributing to cell-cycle arrest. HLJDT increased the expression of Bax and Bak, but decreased the level of Bcl-2 and Bcl-XL, and subsequently triggered the mitochondrial apoptotic pathway. In addition, HLJDT also inhibited cell-survival signaling by enhancing the amount of IκBα in the cytoplasm, reducing the level and activity of NF-κB in the nucleus, and subsequently attenuating the expression of Bcl-XL in Hep G2 and PLC/PRF/5 cells. The inhibitory effect mediated by HLJDT on cell growth was also demonstrated in a nude mouse model, in which the liver cancer cells induced tumor xenograft shrank considerably following treatment with HLJDT. Conclusions: Taken together, these results suggest a potential anticancer effect of HLJDT against human liver cancer cells.

AB - Background and Aim: Huang-lian-jie-du-tang (HLJDT; Japanese name, oren-gedoku-to) is a traditional Chinese medicine prescription known to possess anti-inflammatory activity. Our study reports here for the first time the anticancer effect of HLJDT in two human liver cancer cell lines, Hep G2 and PLC/PRF/5. Methods: Inhibition of cell proliferation by HLJDT was measured by sodium 3′-(1-(phenylamino-carbonyl)-3,4-tetrazolium)-bis(4-methoxy-6- nitro) benzene-sulfonic acid hydrate (XTT) assay. Clonogenic assay was used to elucidate the possible differences in long-term effects of HLJDT on human liver cancer cells. Cell cycle distribution was determined by flow cytometry. Apoptosis was detected using electrophoresis and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick endlabeling (TUNEL) assay. Protein expressions were determined by immunoblot assay. The activity of nuclear factor-kappa B (NF-κB) was determined by Trans-AM ELISA kit. In vivo tumor activity was assessed by xenograft study. Results: HLJDT significantly increased the expression of inactivated phospho-Cdc2 and phospho-Cdc25C, and decreased the levels of cyclin A, cyclin B1, Cdc2, and Cdc25C, thereby contributing to cell-cycle arrest. HLJDT increased the expression of Bax and Bak, but decreased the level of Bcl-2 and Bcl-XL, and subsequently triggered the mitochondrial apoptotic pathway. In addition, HLJDT also inhibited cell-survival signaling by enhancing the amount of IκBα in the cytoplasm, reducing the level and activity of NF-κB in the nucleus, and subsequently attenuating the expression of Bcl-XL in Hep G2 and PLC/PRF/5 cells. The inhibitory effect mediated by HLJDT on cell growth was also demonstrated in a nude mouse model, in which the liver cancer cells induced tumor xenograft shrank considerably following treatment with HLJDT. Conclusions: Taken together, these results suggest a potential anticancer effect of HLJDT against human liver cancer cells.

KW - Apoptosis

KW - Cell cycle

KW - Huang-lian-jie-du-tang

KW - Liver cancer

KW - Nuclear factor-kappa B (NF-κB)

UR - http://www.scopus.com/inward/record.url?scp=47649092000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47649092000&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2008.05390.x

DO - 10.1111/j.1440-1746.2008.05390.x

M3 - Article

VL - 23

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 7 PT2

ER -